Team 4 – Degeneration and plasticity of the locomotor system

© Tous droits réservés
We are investigating motor unit alterations in two very severe human neurodegenerative diseases which lead to motor neuron death and for which no therapies are available currently, namely Spinal Muscular Atrophy (SMA) and Amyotrophic Lateral Sclerosis (ALS). Our ultimate objective is to identify mechanisms the activation of which can be modulated pharmacologically and which have therapeutic potential.
Our project is divided into three axes. The first deals with the study of neuromuscular development and plasticity during normal and pathological embryogenesis. One objective of this study is to identify the molecular mechanisms which control the muscle fiber phenotype, and which could be involved in the pathological aplasia and atrophy detected in ALS and SMA muscles. The second deals with the effects of physical exercise in mouse models of ALS and SMA that could help identify efficient neuroprotective mechanisms, notably for motor neurons, with an aim toward the design of exercise-based rehabilitation protocols for patients. The third objective is to establish the function of the SMN complex in the nucleus, in both the normal and SMA contexts and at identifying the mechanisms that regulate SMN accumulation and release at the Cajal Bodies (CB).
Permanent researchers
Support staff
Post docs and PhD students
Publications |
Article in a journal
2022 1. The cell polarity protein Vangl2 in the muscle shapes the neuromuscular synapse by binding to and regulating the tyrosine kinase MuSK. Boëx M, Cottin S, Halliez M, Bauché S, Buon C, Sans N, Montcouquiol M, Molgó J, Amar M, Ferry A, Lemaitre M, Rouche A, Langui D, Baskaran A, Fontaine B, Messéant J, Strochlic L. Sci Signal. 2022 May 17;15(734):eabg4982. 2. Netrin-1 Secreted by Human Osteoarthritic Articular Chondrocytes Promotes Angiogenesis in Vitro. Akoum J, Corvol MT, Tahiri K, Anract P, Biau D, Borderie D, Étienne F, Rannou F, Nguyen C. Cartilage. 2022 Dec;13(4):94-104 3. Challenges and opportunities for implementing research and science in physical and rehabilitation medicine. Alami S, Roren A, Hervouet L, Azouvi P, Desjeux D, Graciès JM, Lefèvre-ColauMM, Poiraudeau S, Sanchez K, Rannou F, Nguyen C. Ann Phys Rehabil Med. 2022 Dec 1;66(4):101701. 4. Systematic Review of COVID-19-Related Physical Activity-Based Rehabilitations: Benefits to Be Confirmed by More Robust Methodological Approaches. Bailly M, Pélissier L, Coudeyre E, Evrard B, Bingula R, Rochette C, Mériade L, Blavignac C, Fournier AC, Bignon YJ, Rannou F, Dutheil F, Thivel D, Duclos M. Int J Environ Res Public Health. 2022 Jul 25;19(15):9025. 5. Early rehabilitation management strategy for septic arthritis of the knee.Chabaud A, Tetard M, Descamps S, Nguyen C, Rannou F, Tournadre A, Lesens O, Coudeyre E. Infect Dis Now. 2022 May;52(3):170-174. 6. What evidence is needed to demonstrate the beneficial effects of exercise for osteoarthritis? Kloppenburg M, Rannou F, Berenbaum F. Ann Rheum Dis. 2022 Apr;81(4):451-453. 7. Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients.Chenevier-Gobeaux C, Ducastel M, Meritet JF, Ballaa Y, Chapuis N, Pene F, Carlier N, Roche N, Szwebel TA, Terrier B, Borderie D. J Clin Med. 2022 Sep 22;11(19):5560 8. Exposure of human cerebral microvascular endothelial cells hCMEC/D3 to laminar shear stress induces vascular protective responses. Choublier N, Taghi M, Menet MC, Le Gall M, Bruce J, Chafey P, Guillonneau F, Moreau A, Denizot C, Parmentier Y, Nakib S, Borderie D, Bouzinba-Segard H, Couraud PO, Bourdoulous S, Declèves X. Fluids Barriers CNS. 2022 Jun 3;19(1):41. 9. Osteitis in Systemic Sclerosis: a nationwide case-control retrospective study (SCLEROS Study). Cosse C, Kernéis S, Lescoat A, Pugnet G, Truchetet ME, Priollet P, Diot E, Martin M, Maurier F, Viallard JF, Agard C, Granel B, Berthier S, Fagedet D, Watelet B, Toquet S, Luque Paz D, Giret C, Cerles O, Dion J, Nguyen C, Raffray L, Bertolino J, Jourde W, Le Jeunne C, Mouthon L, Chaigne BArthritis Care Res (Hoboken). 2022 May;74(5):809-817 10. Transcutaneous vagus nerve stimulation in erosive hand osteoarthritis:protocol for the randomised, double-blind, sham-controlled ESTIVAL trial. Courties A, Deprouw C, Rousseau A, Berard L, Touati A, Kalsch J, Villevieille M, Maheu E, Miquel A, Simon T, Berenbaum F, Sellam J; ESTIVAL studygroup. BMJ Open. 2022 Mar 22;12(3):e056169. 11. Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway. D’Amico D, Biondi O, Januel C, Bezier C, Sapaly D, Clerc Z, El Khoury M, Sundaram VK, Houdebine L, Josse T, Della Gaspera B, Martinat C, Massaad C, Weill L, Charbonnier F. Neuropathol Appl Neurobiol. 2022 Aug;48(5):e12816. 12. Patient acceptable symptom state for patient-reported outcomes in people with non-specific chronic low back pain. Daste C, Abdoul H, Foissac F, Lefèvre-Colau MM, Poiraudeau S, Rannou F, Nguyen C. Ann Phys Rehabil Med. 2022 Jan;65(1):101451. 13. A link between agrin signalling and Cav 3.2 at the neuromuscular junction in spinal muscular atrophy. Delers P, Sapaly D, Salman B, De Waard S, De Waard M, Lefebvre S. Sci Rep. 2022 Nov 8;12(1):18960. 14. Evolution of Somite Compartmentalization: A View From Xenopus. Della Gaspera B, Weill L, Chanoine C. Front Cell Dev Biol. 2022 Jan 17;9:790847. 15. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19. Ducastel M, Chenevier-Gobeaux C, Ballaa Y, Meritet JF, Brack M, Chapuis N, Pene F, Carlier N, Szwebel TA, Roche N, Terrier B, Borderie D. Int J Mol Sci. 2021 Jul 12;22(14):7462. 16. Gait Alteration Due to Haemophilic Arthropathies in Patients with Moderate Haemophilia. Fouasson-Chailloux A, Leboeuf F, Maugars Y, Trossaert M, Menu P, Rannou F, Vinatier C, Guicheux J, Gross R, Dauty M. Int J Environ Res Public Health. 2022 Jun 20;19(12):7527. 17. Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach. Fuggle N, Bere N, Bruyère O, Rosa MM, Prieto Yerro MC, Dennison E, Dincer F,Gabay C, Haugen IK, Herrero-Beaumont G, Hiligsmann M, Hochberg MC, Laslop A, Matijevic R, Maheu E, Migliore A, Pelletier JP, Radermecker RP, Rannou F,Uebelhart B, Uebelhart D, Veronese N, Vlaskovska M, Rizzoli R, Mobasheri A,Cooper C, Reginster JY. Aging Clin Exp Res. 2022 Sep;34(9):1985-1995. 18. The hamstrings are more impacted than the quadriceps after severe ankle sprain. Grimandi R, Tissier F, Andro C, Tardy D, Gunepin FX, Rannou F, Giroux-Metges MA. Medicine (Baltimore). 2022 Sep 16;101(37):e30251. 19. Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations. Honvo G, Laslop A, Matijevic R, Migliore A, Mobasheri A, Pelletier JP, Prieto Yerro MC, Radermecker RP, Rannou F, Rizzoli R, Reginster JY. Drugs. 2022 Sep;82(13):1347-1355 20. Association of protein-energy partitioning with body weight and body composition changes in adolescents with severe obesity. Isacco L, Lazzer S, Pereira B, Fearnbach N, Montaurier C, Vermorel M, Rannou F, Boirie Y, Thivel D. Int J Obes (Lond). 2022 Nov;46(11):2021-2028. 21. Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial. Kwakkenbos L, Carrier ME, Welling J, Levis B, Levis AW, Sauve M, Turner KA, Tao L, Aguila K, Carboni-Jiménez A, Cañedo-Ayala M, Harb S, van den Ende C, Hudson M, van Breda W, Nguyen C, Boutron I, Rannou F, Thombs BD, Mouthon L; SPIN Investigators. Trials. 2022 Dec 12;23(1):994. 22. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND). Kwakkenbos L, Carrier ME, Welling J, Turner KA, Cumin J, Pépin M, van den Ende C, Schouffoer AA, Hudson M, van Breda W, Sauve M, Mayes MD, Malcarne VL, Nielson WR, Nguyen C, Boutron I, Rannou F, Thombs BD, Mouthon L; SPIN Investigators. PeerJ. 2022 Aug 4;10:e13471 23. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program. Kwakkenbos L, Østbø N, Carrier ME, Nielson WR, Fedoruk C, Levis B, Henry RS, Pope J, Frech T, Gholizadeh S, Johnson SR, Piotrowski P, Jewett LR, Gordon J, Chung L, Bilsker D, Tao L, Turner KA, Cumin J, Welling J, Fortuné C, Leite C, Gottesman K, Sauvé M, Reyna TSR, Hudson M, Larche M, van Breda W, Suarez-Almazor ME, Bartlett SJ, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Benedetti A, Thombs BD; SPIN Investigators. Pilot Feasibility Stud. 2022 Feb 26;8(1):45. 24. Degenerative Lumbar Spine Disease: Imaging and Biomechanics. Lacroix M, Nguyen C, Burns R, Laporte A, Rannou F, Feydy A. Semin Musculoskelet Radiol. 2022 Aug;26(4):424-438. 25. Patient Acceptable Symptom State forBurden From Appearance Changes in People With Systemic Sclerosis: A Cross-sectional Survey. Le Ralle MF, Daste C, Rannou F, Kwakkenbos L, Carrier ME, Lefèvre-Colau MM, Roren A, Thombs BD, Mouthon L, Nguyen C. J Rheumatol. 2022 Aug;49(8):903-907. 26. Low serum progesterone affects live birth rate in cryopreserved blastocyst transfer cycles using hormone replacement therapy. Maignien C, Bourdon M, Marcellin L, Laguillier-Morizot C, Borderie D, Chargui A, Patrat C, Plu-Bureau G, Chapron C, Santulli P. Reprod Biomed Online. 2022 Mar;44(3):469-477 27. Determinants of apprehension to return to sport after reconstruction of the anterior cruciate ligament: an exploratory observational retrospective study. Martini A, Ayala A, Lechable M, Rannou F, Lefèvre-Colau MM, Nguyen C. BMC Sports Sci Med Rehabil. 2022 Mar 15;14(1):37. 28. Effect of Prehabilitation Before Total Knee Replacement for Knee Osteoarthritison Functional Outcomes: A Randomized Clinical Trial. Nguyen C, Boutron I, Roren A, Anract P, Beaudreuil J, Biau D, Boisgard S, Daste C, Durand-Zaleski I, Eschalier B, Gil C, Lefèvre-Colau MM, Nizard R, Perrodeau É, Rabetrano H, Richette P, Sanchez K, Zalc J, Coudeyre E, Rannou F. JAMA Netw Open. 2022 Mar1;5(3):e221462. 29. Intra-articular botulinum toxin A injection for painful base-of-thumb osteoarthritis: a randomized controlled trial (RHIBOT). Nguyen C, Abdoul H, Campagna R, Guerini H, Jilet L, Bedin C, Chagny F, Couraud G, Daste, C, Drapé JL, Fléchon R, Gil C, Guérin C, Lefèvre-Colau MM, Poiraudeau S, Randriamampandry E, Rören A, Feydy A, Rannou F. Lancet Rheumatol. 2022 Jul 1;4(7):e480-e489 30. Marfan’s syndrome with anterior sacral pseudomeningocele. Nguyen C, Jondeau G. Oxf Med Case Reports. 2022 Dec 16;2022(12):omac139 31. Physical activity and low back pain: A critical narrative review. Roren A, Daste C, Coleman M, Rannou F, Freyssenet D, Moro C, Lefèvre-Colau MM, Nguyen C. Ann Phys Rehabil Med. 2022 Nov 30;66(2):101650. 32. Assessing Smoothness of Arm Movements With Jerk: A Comparison of Laterality, Contraction Mode and Plane of Elevation. A Pilot Study. Roren A, Mazarguil A, Vaquero-Ramos D, Deloose JB, Vidal PP, Nguyen C, Rannou F, Wang D, Oudre L, Lefèvre-Colau MM. Front Bioeng Biotechnol. 2022 Jan 21;9:782740. 33. Impact of a multidisciplinary team meeting on patient-reported outcomes at 2 years after lumbar surgery: A prospective comparative exploratory study. Troussier S, Ferrero E, Lefèvre-Colau MM, Feydy A, Guigui P, Rannou F, Nguyen C. Medicine (Baltimore). 2022 Nov 25;101(47):e32091. 34. Exercise therapy program using immersive virtual reality forpeople with non-specific chronic neck pain: A 3-month retrospective open pilotand feasibility study. Zauderer J, Lefèvre-Colau MM, Davoine É, Hocquart M, Rannou F, Roby-Brami A, Nguyen C, Roren A. Ann Phys Rehabil Med. 2022 Mar;65(2):101527 2021 35. Aging Cartilage in Wild-Type Mice: An Observational Study. Akoum J, Tahiri K, Corvol MT, Borderie D, Étienne F, Rannou F, Nguyen C. Cartilage. 2021 Dec;13 (2_suppl):1407S-1411S 36. Pelvic parameters and sagittal alignment in people with chronic low back pain and active discopathy (Modic 1 changes): A case-control study. Blandin C, Boisson M, Segretin F, Teboul-Coré S, Lassalle L, Feydy A, Lefèvre-Colau MM, Rannou F, Nguyen C. Ann Phys Rehabil Med. 2021 Nov;64(6):101364. 37. Conservative treatment for chronic coccydynia: a 36-month prospective observational study of 115 patients. Charrière S, Maigne JY, Couzi E, Lefèvre-Colau MM, Rannou F, Nguyen C. Eur Spine J. 2021 Oct;30(10):3009-3018. 38. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome. Chenevier-Gobeaux C, Lemarechal H, Doumenc B, Peschanski N, Claessens YE, Borderie D, Ray P. Clin Biochem. 2021 Jun;92:19-24. 39. Intervertebral disc therapies for non-specific chronic low back pain: a systematic review and meta-analysis. Daste C, Laclau S, Boisson M, Segretin F, Feydy A, Lefèvre-Colau MM, Rannou F, Nguyen C. Ther Adv Musculoskelet Dis. 2021 Jul 16;13:1759720X211028001. 40. Physical activity for osteoarthritis: Efficiency and review of recommandations.Daste C, Kirren Q, Akoum J, Lefèvre-Colau MM, Rannou F, Nguyen C. Joint Bone Spine. 2021 Dec;88(6):105207. 41. Post-intensive care syndrome in patients surviving COVID-19. Daste C, Ficarra S, Dumitrache A, Cariou A, Lefèbvre A, Pène F, Roche N, Roren A, Thery C, Vidal J, Nguyen C, Rannou F, Lefèvre-Colau MM. Ann Phys Rehabil Med. 2021Nov;64(6):101549. 42. Changes in bone formation regulator biomarkers in early axial spondyloarthritis. Descamps E, Molto A, Borderie D, Lories R, Richard CM, Pons M, Roux C, Briot K. Rheumatology (Oxford). 2021 Mar 2;60(3):1185-1194. 43. Oxidative stress and inflammatory biomarkers for the prediction of severity and ICU admission in unselected patients hospitalized with COVID-19. Ducastel M, Chenevier-Gobeaux C, Ballaa Y, Meritet JF, Brack M, Chapuis N, Pene F, Carlier N, Szwebel TA, Roche N, Terrier B, Borderie D. Int J Mol Sci. 2021 Jul 12;22(14):7462. 44. Rehabilitation and lumbar surgery: the French recommendations for clinicalpractice. Dupeyron A, Ribinik P, Rannou F, Kabani S, Demoulin C, Dufour X, Foltz V, Godard J, Huppert J, Nizard J, Petit A, Silvestre C, Kouyoumdjian P, Coudeyre E. Ann Phys Rehabil Med. 2021 Nov;64(6):101548. 45. Core qualities of an educational program to reduce fears and beliefs of GPs about low back pain: Results of a GPs, experts and literature survey. Facione J, Daste C, Verdaguer C, Lapeyre É, Lefèvre-Colau MM, Rannou F, Nguyen C. J Back Musculoskelet Rehabil. 2021;34(2):221-233. 46. Posttraumatic Osteoarthritis Damage in Mice: From Histological and Micro-Computed Tomodensitometric Changes to Gait Disturbance. Fouasson-Chailloux A, Dauty M, Bodic B, Masson M, Maugars Y, Metayer B, Veziers J, Lesoeur J, Rannou F, Guicheux J, Vinatier C. Cartilage. 2021 Dec; 13(2_suppl):1478S-1489S. 47. Isokinetic knee strength deficit in patients with moderate haemophilia. Fouasson-Chailloux A, Maugars Y, Trossaert M, Rannou F, Menu P, Vinatier C, Guicheux J, Dauty M. Haemophilia. 2021 Jul;27(4):634-640. 48. French recommendations for the management of systemic sclerosis. Hachulla É, Agard C, Allanore Y, Avouac J, Bader-Meunier B, Belot A, Bérezné A, Bouthors AS, Condette-Wojtasik G, Constans J, De Groote P, Diot É, Dumas F, Jego P, Joly F, Launay D, Le Guern V, Le Quintrec JS, Lescaille G, Meune C, Moulin B, Nguyen C, Omeish N, Pène F, Richard MA, Rochefort J, Rören A, Sitbon O, Sobanski V, Truchetet ME, Mouthon L; Collaborators. Orphanet J Rare Dis. 2021 Jul 26;16 (Suppl 2):322 49. Running and Swimming Differently Adapt the BDNF/TrkB Pathway to a Slow Molecular Pattern at the NMJ. Just-Borràs L, Cilleros-Mañé V, Hurtado E, Biondi O, Charbonnier F, Tomàs M, Garcia N, Tomàs J, Lanuza MA. Int J Mol Sci. 2021 Apr 27;22(9):4577. 50. Development of a new patient-reported outcome measure assessing activities and participation in people with lumbar spinal stenosis: The Cochin Spinal Stenosis 19-item questionnaire. Masi C, Couraud G, Daste C, Jouffriault J, Poiraudeau S, LefÈvre-Colau MM, Rannou F, Nguyen C. Eur J Phys Rehabil Med. 2021 Feb;57(1):92-100. 51. Knee Osteoarthritis Pain Management with an Innovative High and Low Molecular Weight Hyaluronic Acid Formulation (HA-HL): A Randomized Clinical Trial. Migliore A, Blicharski T, Plebanski R, Zegota Z, Gyula G, Rannou F, Reginster JY. Rheumatol Ther. 2021 Dec;8(4):1617-1636. 52. Effect of Osteopathic Manipulative Treatment vs Sham Treatment on Activity Limitations in Patients With Nonspecific Subacute and Chronic Low Back Pain: A Randomized Clinical Trial. Nguyen C, Boutron I, Zegarra-Parodi R, Baron G, Alami S, Sanchez K, Daste C, Boisson M, Fabre L, Krief P, Krief G, Lefèvre-Colau MM, Rannou F. JAMA Intern Med. 2021 May 1;181(5):620-630 53. The challenges of precision medicine in chronic low back pain: Lessons learned from active discopathy. Nguyen C, De Sèze M, Rannou F. Ann Phys RehabilMed. 2021 Mar;64(2):101504 54. Home-based cycling using connected ergometric bicycles for people with lumbar spinal stenosis (FLEXCAL): Protocol for a randomised trial. Nguyen C, Boutron I, Roren A, Baron G, Pauwels C, Lefèvre-Colau MM, Poiraudeau S, Dupeyron A, Coudeyre E, Rannou F. Ann Phys Rehabil Med. 2021 Mar;64(2):101351. 55. Muscle Contractile Characteristics During Exhaustive Dynamic Exercise and Recovery. Rannou F, Nybo L, Andersen JE, Nordsborg NB. Front Physiol. 2021 Jul 2;12:660099. 56. The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis – methodology and baseline characteristics of the population. Sellam J, Maheu E, Crema MD, Touati A, Courties A, Tuffet S, Rousseau A,Chevalier X, Combe B, Dougados M, Fautrel B, Kloppenburg M, Laredo JD, Loeuille D, Miquel A, Rannou F, Richette P, Simon T, Berenbaum F. Joint Bone Spine. 2021 Jul;88(4):105171. 57. Can T2-weighted Dixon fat-only images replace T1-weighted images in degenerative disc disease with Modic changes on lumbarspine MRI? Yang S, Lassalle L, Mekki A, Appert G, Rannou F, Nguyen C, Lefèvre-Colau MM, Mutschler C, Drapé JL, Feydy A. Eur Radiol. 2021 Dec;31(12):9380-9389 58. Mechanical loading activates the YAP/TAZ pathway and chemokine expression in the MLO-Y4 osteocyte-like cell line. Zarka M, Etienne F, Bourmaud M, Szondi D, Schwartz JM, Kampmann K, Helary C, Rannou F, Haÿ E, Cohen-Solal M. Lab Invest. 2021 Dec;101(12):1597-1604.
2020 59. New recessive mutations in SYT2 causing severe presynaptic congenital myasthenic syndromes. Bauché S, Sureau A, Sternberg D, Rendu J, Buon C, Messéant J, Boëx M, Furling D, Fauré J, Latypova X, Gelot AB, Mayer M, Mary P, Whalen S, Fournier E, Cloix I, Remerand G, Laffargue F, Nougues MC, Fontaine B, Eymard B, Isapof A, Strochlic L. Neurol Genet. 2020 Dec 3;6(6):e534. 60. Changes in gut microbiota by chronic stress affect the efficacy of fluoxetine. Siopi E, Chevalier G, Bigot M, Katsimpardi L, Saha S, Moigneu C, Eberl G and Lledo P.M. Cell Reports, 2020 ; 30: 3682-3690. 61. The impact of gut microbiota on depressive-like behaviors and adult hippocampal neurogenesis requires the endocannabinoid system. Chevalier C, Siopi E, Guenin-Macé L, Pascal M, Laval T, Rifflet A, Boneca I, Demangel C, Leulier F, Lepousez G, Eberl G and Lledo P.M. Nature Communications, 2020 ; 11: 6363. 62. Lumbosacral immobilization following glucocorticoid intradiscal injection in patients with chronic low back pain and active discopathy: A feasibility study. Couzi E, Boisson M, Segretin F, Lefèvre-Colau MM, Roren A, Moreau S, Goret S, Poiraudeau S, Rannou F, Nguyen C. Back Musculoskelet Rehabil. 2020;33(6):931-937. 63. Development of a new patient-reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17-item Scleroderma Functional scale. Daste C, Abdoul H, Foissac F, Papelard A, Alami S, Kwakkenbos L, Carrier ME, Lefèvre-Colau MM, Thombs BD, Poiraudeau S, Rannou F, Mouthon L, Nguyen C. Br J Dermatol. 2020 Oct;183(4):710-718. 64. Neuralgic amyotrophy and hepatitis E infection: 6 prospective case reports. Garofoli R, Zauderer J, Seror P, Roren A, Guerini H, Rannou F, Drapé JL, Nguyen C, Lefèvre-Colau MM. RMD Open. 2020 Nov;6(3):e001401 65. Running and swimming prevent the deregulation of the BDNF/TrkB neurotrophic signalling at the neuromuscular junction in mice with amyotrophic lateral sclerosis. Just-Borràs L, Hurtado E, Cilleros-Mañé V, Biondi O, Charbonnier F, Tomàs M, Garcia N, Tomàs J, Lanuza MA. Cell Mol Life Sci. 2020 Aug;77(15):3027-3040. 66. AChR β-Subunit mRNAs Are Stabilized by HuR in a Mouse Model of Congenital Myasthenic Syndrome With Acetylcholinesterase Deficiency. Karmouch J, Delers P, Semprez F, Soyed N, Areias J, Bélanger G, Ravel-Chapuis A, Dobbertin A, Jasmin BJ, Legay C. Front Mol Neurosci. 2020 Dec 9;13:568171. 67. Pathogenesis and therapeutic targets in spinal muscular atrophy. Lefebvre S, Sarret C. Arch Pediatr 2020 Dec;27(7S):7S3-7S8. 68. Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France on volume and cost of drug deliveries, assessed with administrative databases. Mari K, Rannou F, Guillemin F, Elegbede M, Gueyffier F, Badot G, MistrettaF. Semin Arthritis Rheum. 2020 Dec;50(6):1307-1313. 69. Identification of TGFβ signatures in six murine models mimicking different osteoarthritis clinical phenotypes. Maumus M, Noël D, Ea HK, Moulin D, Ruiz M, Hay E, Houard X, Cleret D, Cohen-Solal M, Jacques C, Jouzeau JY, Lafage-Proust MH, Reboul P, Sellam J, Vinatier C, Rannou F, Jorgensen C, Guicheux J, Berenbaum F. Osteoarthritis Cartilage. 2020 Oct;28(10):1373-1384. 70. Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trial. Mircher C, Sacco S, Bouis C, Gallard J, Pichot A, Le Galloudec E, Cieuta C,Marey I, Greiner-Mahler O, Dorison N, Gambarini A, Stora S, Durand S, Polak M, Baruchel A, Schlumberger E, Dewailly J, Azar-Kolakez A, Guéant-Rodriguez RM, Guéant JL, Borderie D, Bonnefont-Rousselot D, Blondiaux E, Ravel A, Sturtz FG. Genet Med. 2020 Jan;22(1):44-52. 71. The ratio of maximal handgrip force and maximal cycloergometry power as a diagnostic tool to screen for metabolic myopathies. Noury JB, Zagnoli F, Petit F, Le Maréchal C, Marcorelles P, Rannou F. Sci Rep. 2020 Jun 1;10(1):8865 72. Exercise efficiency impairment in metabolic myopathies. Noury JB, Zagnoli F, Petit F, Marcorelles P, Rannou F. Sci Rep. 2020 May 29;10(1):8765. 73. The Annals of Physical and Rehabilitation Medicine through the 2010s:A generalist journal of rehabilitation with a French touch. Pérennou D, Azouvi P, Nadeau S, Casillas JM, Burger H, Denys P, Coudeyre E, Rannou F. Ann Phys Rehabil Med. 2020 Jan;63(1):1-3. 74. Usefulness of intravenous contrast-enhanced MRI for diagnosis of adhesive capsulitis. Pessis E, Mihoubi F, Feydy A, Campagna R, Guerini H, Roren A, Rannou F, Drapé JL, Lefèvre-Colau MM. Eur Radiol. 2020 Nov;30(11):5981-5991 75. Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed. Renassia C, Louis S, Cuvellier S, Boussetta N, Deschemin JC, Borderie D, Bailly K, Poupon J, Dang PM, El-Benna J, Manceau S, Lefrère F, Vaulont S, Peyssonnaux C. Blood Adv. 2020 Aug 25;4(16):3853-3863. 76. Arm elevation involves cervical spine 3-D rotations. Roren A, Nguyen C, Zauderer J, Acapo S, Rannou F, Roby-Brami A, Lefèvre-Colau MM. Ann Phys Rehabil Med. 2020 Jul;63(4):372-375. 77. The Small-Molecule Flunarizine in Spinal Muscular Atrophy Patient Fibroblasts Impacts on the Gemin Components of the SMN Complex and TDP43, an RNA-Binding Protein Relevant to Motor Neuron Diseases. Sapaly D, Delers P, Coridon J, Salman B, Letourneur F, Dumont F, Lefebvre S. Front Mol Biosci. 2020 April 17; 7: 55. 78. Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis. Sellam J, Courties A, Eymard F, Ferrero S, Latourte A, Ornetti P, BannwarthB, Baumann L, Berenbaum F, Chevalier X, Ea HK, Fabre MC, Forestier R, Grange L, Lellouche H, Maillet J, Mainard D, Perrot S, Rannou F, Rat AC, Roux CH, Senbel E, Richette P; French Society of Rheumatology. Joint Bone Spine. 2020 Dec;87(6):548-555 79. Voluntary winging of the scapula: Proposed diagnostic criteria. Seror P, Roren MA, Garofoli R, Zauderer J, Rannou F, Lefevre-Colau MM. Muscle Nerve. 2020 Nov;62(5):611-616. 80. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, Almire C, Hénon C, Kosmider O, Droin N, Rameau P, Catelain C, Alfaro A, Dussiau C, Friedrich C, Sourdeau E, Marin N, Szwebel TA, Cantin D, Mouthon L, Borderie D, Deloger M, Bredel D, Mouraud S, Drubay D, Andrieu M, Lhonneur AS, Saada V, Stoclin A, Willekens C, Pommeret F, Griscelli F, Ng LG, Zhang Z, Bost P, Amit I, Barlesi F, Marabelle A, Pène F, Gachot B, André F, Zitvogel L, Ginhoux F, Fontenay M, Solary E. Cell. 2020 Sep 17;182(6):1401-1418.e18. 2019 81. Physical or Occupational Therapy Use in Systemic Sclerosis: AScleroderma Patient-centered Intervention Network Cohort Study. Becetti K, Kwakkenbos L, Carrier ME, Gordon JK, Nguyen JT, Mancuso CA, Mouthon L, Nguyen C, Rannou F, Welling J, Thombs BD, Spiera RF; SPIN Investigators. J Rheumatol. 2019 Dec;46(12):1605-1613. 82. Serum biomarkers in people with chronic low back pain and Modic 1 changes: a case-control study. Boisson M, Borderie D, Henrotin Y, Teboul-Coré S, Lefèvre-Colau MM, Rannou F, Nguyen C. Sci Rep. 2019 Jul 10;9(1):10005. 83. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Bruyère O, Honvo G, Veronese N, Arden NK, Branco J, Curtis EM, Al-Daghri NM, Herrero-Beaumont G, Martel-Pelletier J, Pelletier JP, Rannou F, Rizzoli R, Roth R, Uebelhart D, Cooper C, Reginster JY. Semin Arthritis Rheum. 2019 Dec;49(3):337-350. 84. Diagnosis and management of lumbar spinal stenosis in primary care in France: a survey ofgeneral practitioners. Chagnas MO, Poiraudeau S, Lefèvre-Colau MM, Rannou F, Nguyen C. BMC Musculoskelet Disord. 2019 Sep 14;20(1):431. 85. Pre-, post- or no acidification of urine samples for calcium analysis: does it matter? Chenevier-Gobeaux C, Rogier M, Dridi-Brahimi I, Koumakis E, Cormier C, Borderie D. Clin Chem Lab Med. 2019 Dec 18;58(1):33-39. 86. Mechanical Stretch of High Magnitude Provokes Axonal Injury, Elongation of Paranodal Junctions, and Signaling Alterations in Oligodendrocytes. Chierto E, Simon A, Castoldi F, Meffre D, Cristinziano G, Sapone F, Carrete A, Borderie D, Etienne F, Rannou F, Morrison B 3rd, Massaad C, Jafarian-Tehrani MMol Neurobiol. 2019 Jun;56(6):4231-4248. 87. Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say? Cooper C, Chapurlat R, Al-Daghri N, Herrero-Beaumont G, Bruyère O, Rannou F, Roth R, Uebelhart D, Reginster JY. Drugs Aging. 2019 Apr;36(Suppl 1):15-24. 88. Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care. Daste C, Rannou F, Mouthon L, Sanchez K, Roren A, Tiffreau V, Hachulla É, Thoumie P, Cabane J, Chatelus E, Sibilia J, Poiraudeau S, Nguyen C. Semin Arthritis Rheum. 2019 Feb;48(4):694-700. 89. Lineage tracing of sclerotome cells in amphibian reveals that multipotent somitic cells originate from lateral somitic frontier. Della Gaspera B, Mateus A, Andéol Y, Weill L, Charbonnier F, Chanoine C. Dev Biol. 2019 Sep 1;453(1):11-18. 90. Feasibility of a short multidisciplinary education and exercise therapy program for patients with non-specific low back pain: A 3-month retrospective open pilot study. Garofoli R, Boisson M, Segretin F, Linières J, Gérard C, Moreau S, Ieong E, Chagny F, Bedin C, Lefèvre-Colau MM, Rannou F, Roren A, Nguyen C. Ann Phys Rehabil Med. 2019 Sep;62(5):382-385. 91. . Collagen XXV promotes myoblast fusion during myogenic differentiation and muscle formation. Gonçalves TJM, Boutillon F, Lefebvre S, Goffin V, Iwatsubo T, Wakabayashi T, Oury F, Armand ASSci Rep. 2019 Apr 10;9(1):5878. 92. Physical Activity Enhancement Patient Advisory Team. Identifying barriers and facilitators to physical activity for people with scleroderma: a nominal group technique study. Harb S, Cumin J, Rice DB, Peláez S, Hudson M, Bartlett SJ, Rören A, Furst DE, Frech TM, Nguyen C, Nielson WR, Thombs BD, Shrier I; Scleroderma Patient-centered Intervention Network. Disabil Rehabil. 2020 Mar 19:1-8 93. Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Honvo G, Bannuru RR, Bruyère O, Rannou F, Herrero-Beaumont G, Uebelhart D, Cooper C, Arden N, Conaghan PG, Reginster JY, Thomas T, McAlindon T. Drugs Aging. 2019 Apr;36(Suppl 1):145-159. 94. Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Honvo G, Reginster JY, Rannou F, Rygaert X, Geerinck A, Rabenda V, McAlindon T, Charles A, Fuggle N, Cooper C, Curtis E, Arden N, Avouac B, Bruyère O. Drugs Aging. 2019 Apr;36(Suppl 1):101-127. 95. Low-Intensity Running and High-Intensity Swimming Exercises Differentially Improve Energy Metabolism in Mice With Mild Spinal Muscular Atrophy. Houdebine L, D’Amico D, Bastin J, Chali F, Desseille C, Rumeau V, Soukkari J, Oudot C, Rouquet T, Bariohay B, Roux J, Sapaly D, Weill L, Lopes P, Djouadi F, Bezier C, Charbonnier F, Biondi O. Front Physiol. 2019 Oct 1;10:1258. 96. Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice. Just-Borràs L, Hurtado E, Cilleros-Mañé V, Biondi O, Charbonnier F, Tomàs M, Garcia N, Lanuza MA, Tomàs J. Mol Neurobiol. 2019 Oct;56(10):6856-6872. 97. Factors associated with patient-reported likelihood of using online self-care interventions: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study. Kwakkenbos L, Cumin J, Carrier ME, Bartlett SJ, Malcarne VL, Mouthon L, Nielson WR, Rannou F, Welling J, Thombs BD; SPIN Investigators. BMJ Open. 2019 Oct 14;9(10):e029542. 98. Type II collagen peptide Coll2-1 is an actor of synovitis. Lambert C, Borderie D, Dubuc JE, Rannou F, Henrotin Y. Osteoarthritis Cartilage. 2019 Nov;27(11):1680-1691 99. Impact of a specific training programme on the neuromodulation of pain in female patient with fibromyalgia (DouFiSport): a 24-month, controlled, randomised, double-blind protocol. Le Fur Bonnabesse A, Cabon M, L’Heveder G, Kermarrec A, Quinio B, Woda A, Marchand S, Dubois A, Giroux-Metges MA, Rannou F, Misery L, Bodéré C. BMJ Open. 2019 Jan 25;9(1):e023742. 100. A new decision tree for diagnosis of osteoarthritis in primary care: international consensus of experts. Martel-Pelletier J, Maheu E, Pelletier JP, Alekseeva L, Mkinsi O, Branco J, Monod P, Planta F, Reginster JY, Rannou F. Aging Clin Exp Res. 2019 Jan;31(1):19-30. 101. Construction of an ICF core set and ICF-based questionnaire assessing activities and participation in patients with systemic sclerosis. Papelard A, Daste C, Alami S, Sanchez K, Roren A, Segretin F, Lefèvre-Colau MM, Rannou F, Mouthon L, Poiraudeau S, Nguyen C. Rheumatology (Oxford). 2019 Dec 1;58(12):2260-2272. 102. Responders to intradiscal glucocorticoid among patients with chronic low back pain and active discopathy. Pauwels C, Daste C, Poiraudeau S, Lefèvre-Colau MM, Rannou F, Nguyen C. Rheumatology (Oxford). 2019 Sep 1;58(9):1689-1690. 103. Monitoring Muscle Fatigue Progression during Dynamic Exercise. Rannou F, Nybo L, Andersen JE, Nordsborg NB. Med Sci Sports Exerc. 2019 Jul;51(7):1498-1505. 104. Exercise programmes for ankylosing spondylitis.Regnaux JP, Davergne T, Palazzo C, Roren A, Rannou F, Boutron I, Lefevre-Colau MM. Cochrane Database Syst Rev. 2019 Oct 2;10(10):CD011321. 105. Non-linearity and gaps in results distribution over successive Roche Lipase method applications: improvement but persistence. Robert de Rancher MA, Gobeaux-Chenevier C, Lemarechal H, Alkouri R, Borderie D, Bonnefont-Rousselot D, Monneret D. Scand J Clin Lab Invest. 2019 Dec;79(8):572-578. 106. TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis. Ruiz M, Maumus M, Fonteneau G, Pers YM, Ferreira R, Dagneaux L, Delfour C, Houard X, Berenbaum F, Rannou F, Jorgensen C, Noël D. Osteoarthritis Cartilage. 2019 Mar;27(3):493-503. 2018 107. Microbiome influences prenatal and adult microglia in a sex specific manner. Thion M, Low D, Silvin A, Chen J, Grisel P, Schulte-Schrepping J, Blecher R, Ulas T, Squarzoni P, Hoeffel G, Coulpier F, Siopi E, David FS, Scholz C, Shihui F, LumJ, Amoyo A, Larbi A, Poidinger M, Buttgereit A, Lledo PM, Greter M, JKY Chan, Amit I, Beyer M, Ludwig Schultze J, Schlitzer A, Pettersson S, Ginhoux F, Garel S. Cell, 2018 ; 172: 500-516 108. Active discopathy: a clinical reality. Boisson M, Lefèvre-Colau MM, Rannou F, Nguyen C. RMD Open. 2018 Apr 17;4(1):e000660. 109. Polymethylmethacrylate-induced Modic 1 changes following percutaneous vertebroplasty and intradiscal cement leakage: A case report. Boisson M, Rannou F, Nguyen C. Joint Bone Spine. 2019 110. A decision-making tool to prescribe knee orthoses in daily practice for patients with osteoarthritis. Coudeyre E, Nguyen C, Chabaud A, Pereira B, Beaudreuil J, Coudreuse JM, Deat P, Sailhan F, Lorenzo A, Rannou F. Ann Phys Rehabil Med. 2018 Mar;61(2):92-98. 111. Xenopus SOX5 enhances myogenic transcription indirectly through transrepression. Della Gaspera B, Chesneau A, Weill L, Charbonnier F, Chanoine C. Dev Biol. 2018 Oct 15;442(2):262-275. 112. Clinical relevance of 3D gait analysis in patients with haemophilia. Fouasson-Chailloux A, Maugars Y, Vinatier C, Trossaert M, Menu P, Rannou F, Guicheux J, Dauty M. Haemophilia. 2018 Sep;24(5):703-710. 113. Intra-articular botulinum toxin A for base-of-thumb osteoarthritis: protocol for a randomised trial (RHIBOT). Gil C, Abdoul H, Campagna R, Guerini H, Ieong E, Chagny F, Bedin C, Roren A, Lefèvre-Colau MM, Poiraudeau S, Feydy A, Rannou F, Nguyen C. BMJ Open. 2018 Jun 30;8(6):e022337. 114. Radicular claudication revealing possible acrodysostosis: A case report. Jalabert M, Rannou F, Nguyen C. Ann Phys Rehabil Med. 2018 Jan;61(1):60-61. 115. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis. Hilhorst M, Maria AT, Kavian N, Batteux F, Borderie D, Le Quellec A, van Paassen P, Guilpain P. Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1769-F1776. 116. Liver X Receptor exerts a protective effect against the oxidative stress in the peripheral nerve. Hichor M, Sundaram VK, Eid SA, Abdel-Rassoul R, Petit PX, Borderie D, Bastin J, Eid AA, Manuel M, Grenier J, Massaad C. Sci Rep. 2018 Feb 6;8(1):2524 117. Resveratrol Self-Emulsifying Systems in T/C28a2 Cell Line as Beneficial Effectors in Cellular Uptake and Protection Against Oxidative Stress-Mediated Death. Le Clanche S, Cheminel T, Rannou F, Bonnefont-Rousselot D, Borderie D, Charrueau C. Use of Front Pharmacol. 2018 May 24;9:538. 118. Kinematic patterns in normal and degenerative shoulders. Part II: Review of 3-D scapular kinematic patterns in patients with shoulder pain and clinical implications. Lefèvre-Colau MM, Nguyen C, Palazzo C, Srour F, Vuillemin V, Paris G, Poiraudeau S, Roby-Brami A, Rören A. Ann Phys Rehabil Med. 2018 Jan;61(1):46-53 119. Recent advances on the kinematics of the shoulder complex in healthy subjects. Lefèvre-Colau MM, Nguyen C, Palazzo C, Srour F, Paris G, Vuillemin V, Poiraudeau S, Roby-Brami A, Rören A. Ann Phys Rehabil Med. 2018 Jan;61(1):56-59 120. Low back pain. Nguyen C, Lefèvre-Colau MM, Kennedy DJ, Schneider BJ, Rannou F. Lancet. 2018 Dec 15;392(10164):2547 121. Exercise testing-based algorithms to diagnose McArdle disease and MAD defects. Noury JB, Zagnoli F, Carré JL, Drouillard I, Petit F, Le Maréchal C, Marcorelles P, Rannou F. Acta Neurol Scand. 2018 Oct;138(4):301-307. 122. Home-based cycling program tailored to older people with lumbar spinal stenosis: Barriers and facilitators. Pauwels C, Roren A, Gautier A, Linières J, Rannou F, Poiraudeau S, Nguyen C. Ann Phys Rehabil Med. 2018 May;61(3):144-150 123. An impact factor for the 60 candles of the Annals. Pérennou D, Thevenon A, Rannou F, Azouvi P, Coudeyre E, Amarenco G, Casillas JM, Nadeau S, Laffont I, Remy-Neris O, Yelnik A, Joseph PA, Rode G. Ann Phys Rehabil Med. 2018 Jan;61(1):1-4 124. Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Reginster JL, Arden NK, Haugen IK, Rannou F, Cavalier E, Bruyère O, Branco J, Chapurlat R, Collaud Basset S, Al-Daghri NM, Dennison EM, Herrero-Beaumont G, Laslop A, Leeb BF, Maggi S, Mkinsi O, Povzun AS, Prieto-Alhambra D, Thomas T, Uebelhart D, Veronese N, Cooper C. Semin Arthritis Rheum. 2018 125. Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy. Sapaly D, Dos Santos M, Delers P, Biondi O, Quérol G, Houdebine L, Khoobarry K, Girardet F, Burlet P, Armand AS, Chanoine C, Bureau JF, Charbonnier F, Lefebvre S. Sci Rep. 2018 Feb 1;8(1):2075. 126. Unilateral winged scapula: clinical and electrodiagnostic experience with 128 cases, with special attention to long thoracic nerve palsy. Seror P, Lenglet T, Nguyen C, Ouaknine M, Lefèvre-Colau MM. Muscle Nerve. 2018 Jun;57(6):913-920 127. Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis. Shackleford G, Sampathkumar NK, Hichor M, Weill L, Meffre D, Juricek L, Laurendeau I, Chevallier A, Ortonne N, Larousserie F, Herbin M, Bièche I, Coumoul X, Beraneck M, Baulieu EE, Charbonnier F, Pasmant E, Massaad C. Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1319-E1328. 128. Bone mineral density and bone remodeling markers in chronic low back pain patients with active discopathy: A case-control exploratory study. Teboul-Coré S, Roux C, Borderie D, Kolta S, Lefèvre-Colau MM, Poiraudeau S, Rannou F, Nguyen C. PLoS One. 2018 Jun 29;13(6):e0196536.
2017 129. Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy. Bauché S, Vellieux G, Sternberg D, Fontenille MJ, De Bruyckere E, Davoine CS, Brochier G, Messéant J, Wolf L, Fardeau M, Lacène E, Romero N, Koenig J, Fournier E, Hantaï D, Streichenberger N, Manel V, Lacour A, Nadaj-Pakleza A, Sukno S, Bouhour F, Laforêt P, Fontaine B, Strochlic L, Eymard B, Chevessier F, Stojkovic T, Nicole S. J Neurol. 2017 Aug;264(8):1791-1803. 130. Wnt proteins contribute to neuromuscular junction formation through distinct signaling pathways. Messéant J, Ezan J, Delers P, Glebov K, Marchiol C, Lager F, Renault G, Tissir F, Montcouquiol M, Sans N, Legay C, Strochlic L. Development. 2017 May 1;144(9):1712-1724. 131. Plasmatic presepsin (sCD14-ST) concentrations in acute pyelonephritis in adult patients. Claessens YE, Trabattoni E, Grabar S, Quinquis L, Der Sahakian G, Anselmo M, Schmidt J, de la Coussaye JE, Plaisance P, Casalino E, Potel G, Lecomte F, Borderie D, Chenevier-Gobeaux C. Clin Chim Acta. 2017 Jan;464:182-188. 132. Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice. Cooper C, Rannou F, Richette P, Bruyère O, Al-Daghri N, Altman RD, Brandi ML, Collaud Basset S, Herrero-Beaumont G, Migliore A, Pavelka K, Uebelhart D, Reginster JY. Arthritis Care Res (Hoboken). 2017 Sep;69(9):1287-1296. 133. Specific Physical Exercise Improves Energetic Metabolism in the Skeletal Muscle of Amyotrophic-Lateral- Sclerosis Mice. Desseille C, Deforges S, Biondi O, Houdebine L, D’amico D, Lamazière A, Caradeuc C, Bertho G, Bruneteau G, Weill L, Bastin J, Djouadi F, Salachas F, Lopes P, Chanoine C, Massaad C, Charbonnier F. Front Mol Neurosci. 2017 Oct 20;10:332. 134. Focal chondropathy of the far posterior femoral condyle: an unusual cause of posterior knee pain. Fabre S, Lefèvre-Colau MM, Bourdet C, Feydy A, Poiraudeau S, Rannou F, Nguyen C. Ann Phys Rehabil Med. 2017 Apr;60(2):120-122. 135. Case-Finding for Persistent Airway Obstruction in Farmers: A Questionnaire With Optimal Diagnosis Criteria. Guillien A, Soumagne TE, Puyraveau M, Berger P, Guillot SL, Rannou F, Jouneau S, Mauny FJ, Laplante JJ, Dalphin JC, Degano B. Am J Prev Med. 2017 Dec;53(6):837-844. 136. Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial. Henrotin Y, Berenbaum F, Chevalier X, Marty M, Richette P, Rannou F. BMC Musculoskelet Disord. 2017 May 26;18(1):222. 137. Paraquat Induces Peripheral Myelin Disruption and Locomotor Defects: Crosstalk with LXR and Wnt Pathways.Hichor M, Sampathkumar NK, Montanaro J, Borderie D, Petit PX, Gorgievski V, Tzavara ET, Eid AA, Charbonnier F, Grenier J, Massaad C. Antioxid Redox Signal. 2017 Jul 20;27(3):168-183 138. Wnt proteins contribute to neuromuscular junction formation through distinct signaling pathways. Messéant J, Ezan J, Delers P, Glebov K, Marchiol C, Lager F, Renault G, Tissir F, Montcouquiol M, Sans N, Legay C, Strochlic L. Development. 2017 May 1;144(9):1712-1724. 139. Intensive spa and exercise therapy program for returning to work for low back pain patients: a randomized controlled trial. Nguyen C, Boutron I, Rein C, Baron G, Sanchez K, Palazzo C, Dupeyron A, Tessier JM, Coudeyre E, Eschalier B, Forestier R, Roques-Latrille CF, Attal Y, Lefèvre-Colau MM, Rannou F, Poiraudeau S. Sci Rep. 2017 Dec 20;7(1):17956. 140. Evolution of pain at 3 months by oral resveratrol in knee osteoarthritis (ARTHROL): protocol for a multicentre randomised double-blind placebo-controlled trial. Nguyen C, Boutron I, Baron G, Coudeyre E, Berenbaum F, Poiraudeau S, Rannou F. BMJ Open. 2017 Sep 29;7(9):e017652. 141. The safety of intra-articular injections for thetreatment of knee osteoarthritis: a critical narrative review. Nguyen C, Rannou F. Expert Opin Drug Saf. 2017 Aug;16(8):897-902. 142. Intradiscal Glucocorticoid Injection for Patients With Chronic Low Back Pain Associated With Active Discopathy: A Randomized Trial. Nguyen C, Boutron I, Baron G, Sanchez K, Palazzo C, Benchimol R, Paris G, James-Belin É, Lefèvre-Colau MM, Beaudreuil J, Laredo JD, Béra-Louville A, Cotten A, Drapé JL, Feydy A, Ravaud P, Rannou F, Poiraudeau S. Ann Intern Med. 2017 Apr 18;166(8):547-556. 143. Intervertebral disc and vertebral endplate subchondral changes associated with Modic 1 changes of the lumbar spine: a cross-sectional study. Nguyen C, Jousse M, Poiraudeau S, Feydy A, Rannou F. BMC Musculoskelet Disord. 2017 Jan 23;18(1):34 144. Resveratrol, Potential Therapeutic Interest in Joint Disorders: A Critical Narrative Review. Nguyen C, Savouret JF, Widerak M, Corvol MT, Rannou F. Nutrients. 2017 Jan 6;9(1):45. 145. Lack of effectiveness of antibiotics in chronic low back pain with Modic 1 changes. Palazzo C, Ferrari M, Lefèvre-Colau MM, Nguyen C, Rannou F, Poiraudeau S. Joint Bone Spine. 2017 Jul;84(4):507-508 146. Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency. Rannou F, Scotet V, Marcorelles P, Monnoyer R, Le Maréchal C. PLoS One. 2017 Nov 2;12(11):e0187266. 147. Kinematic analysis of the shoulder complex after anatomic and reverse total shoulder arthroplasty: A cross-sectional study. Rören A, Nguyen C, Palazzo C, Fayad F, Revel M, Grégory T, Poiraudeau S, Roby-Brami A, Lefèvre-Colau MM. Musculoskelet Sci Pract. 2017 Jun;29:84-90 148. Musashi 1 regulates the timing and extent of meiotic mRNA translational activation by promoting the use of specific CPEs. Weill L, Belloc E, Castellazzi CL, Méndez R. Nat Struct Mol Biol. 2017 Aug;24(8):672-681.
|
Communication in a conference
Bézier C. Combination of BIO101 with antisense oligonucleotide therapy demonstrates synergistic beneficial effects in severe SMA-like mice. Cure SMA, Annual Research & Clinical Care Meeting, Anaheim, USA, 2022. Bézier C. Combination of antisense oligonucleotide therapy with BIO101 demonstrates synergistic beneficial effects in severe SMA-like mice. 17th International Congress on Neuromuscular Diseases (ICNMD), Brussels, Belgium, 2022. Bézier C. Combination of BIO101 with antisense oligonucleotide therapy demonstrates synergistic beneficial effects in severe SMA-like mice. 7th International Myology Congress, Nice, France, 2022. Bézier C. Combination of BIO101 with antisense oligonucleotide therapy demonstrates synergistic beneficial effects in severe SMA-like mice. 27th International Annual Congress of the World Muscle Society (WMS), Halifax, Canada, 2022. Bézier C. Synergistic beneficial effects of BIO101 in combination with antisense oligonucleotide therapy in severe SMA-like mice. 3rd International Scientific Congress on Spinal Muscular Atrophy, Barcelona, Spain, 2022. Charbonnier F. Therapeutic approaches to treat SMA : targets and mechanism of action, Roche Symposium, JSFM Toulouse, 2022 Lefebvre S. L’amyotrophie spinale de la génétique à la thérapie, Colloque Fondation Maladies Rares, Collège de France, 2022 Lefebvre S. Génétique de l’amyotrophie spinale: Découverte du gène Survival Motor Neuron 1 (SMN1) XXIIIièmes entretiens annuels de la Fondation Garches, 2021 Lefebvre S. Le gène Survival Motor Neuron 1 (SMN1): Découverte d’une cible thérapeutique, Novartis Symposium, JSFM Saint-Etienne, 2021 Lefebvre S. The SMN complex in motor neuron diseases, Motor neuron diseases. Understanding the pathogenetic mechanisms to develop therapies, Virtual, 2020 Lefebvre S. Physiopathologie de la SMA. Rôle de la protein SMN, Séminaire Nationale Biogen, Cannes, 2020 Lefebvre S. Rôle de la protein SMN dans la physiologie de l’amyotrophie spinale infantile, Sessions Intéractives consacrées à la SMA (SISMA), Biogen, Paris, 2019 Lefebvre S. The use of flunarizine in a mouse model of severe spinal muscular atrophy to reveal dysregulated pathways, European Mini-Symposium « Let’s meet at the neuromuscular junction, Paris, 2018 Lefebvre S. Altered RNA metabolism in motor neuron diseases, Meeting on Cross-disease analysis of pathways in amyloid-based neurodegenerative diseases symposium, Paris, 2017 D’Amico D. Restoring the IRE1α-XBP1 branch of unfolded protein response in spinal muscular atrophy stimulates SMN expression, IPNP conference, Paris 2019 Rannou F. 10 international and national communications per year in the field of osteoarthritis, spine and musculoskeletal research for the following international (ESCEO, EULAR, OARSI, MSK, Osteorheumatology, University of Leuven, Mediteranean congres of PMR) and national (SFR, SOFMER, SFETD, ARCIF, Russian Society of Rheumatology, Ukrainian Society of Rheumatology, Moroccan Society of PMR, Algerian Society of PMR) scientific societies. |
Posters (détails non obligatoires – voir FAQ HCERES) · Donner le nombre de posters de l’équipe de 2017-2022 dans des conf. Nationales 3 (JSFM St-Etienne 2021), 3 (JSFM Toulouse 2022 ) · Donner le nombre de posters de l’équipe de 2017-2022 dans des conf. internationales 3 (Myology, Bordeaux 2019), 1 (Myology, Nice, 2022), 1 (Barcelona, 2022). |
Proceedings/Recueil des communications (si relevant)
Profiling of low back pain patients for the design of a tailored coaching application. Debackere F, Clavel C, Rören A, Tran VT, Snoubra G, Messai Y, Rannou F, Nguyen C, Martin JC. 10th international conference on affective computing & intelligent interaction 2022. Nara (Japon), October 2022. |
Book (including critical edition and translation)
C. Chanoine, J.L. Laplanche. « Bases cellulaires et moléculaires de la cellule eucaryotes- Exercices et QCM». Ellipses 2021 C. Chanoine. «Bases cellulaires et moléculaires du développement ». Ellipses 2007, 2016, 2020 C. Chanoine. «Bases cellulaires et moléculaires du développement – Méthodes et exercices ». Ellipses 2009, 2011, 2016, 2020 C. Chanoine, F. Charbonnier. « Bases cellulaires et moléculaires de la cellule eucaryotes ». Ellipses, 2011, 2018 C. Chanoine. « Histoire de la biologie du développement – De l’Antiquité à nos jours ». Ellipses, 2018 |
Book chapter S Lefebvre, «Lumière sur l’amyotrophie spinale ou SMA, une maladie du motoneurone», Brochure sur tablette destinée aux praticiens et familles en milieux hospitaliers, Together with Biogen, 2020 Lefèvre-Colau MM, Roren A, Nguyen C, Rannou F. Proprioception cervicale et performance posturale (2021). Nguyen C, Rannou F. Neck pain. EULAR online course on Rheumatic Diseases. Édition 2021-2024 |
|
Patents · Titre du brevet – personnes signataires de l’équipe – Année – Statut 1) Patent FR 2111920-2022: “Phytoecdysones et/ou dérivés de 20- hydroxyecdysone en combinaison avec un principe actif visant à restaurer l’expression smn pour leur utilisation dans le traitement de l’amyotrophie spinale”. 2022. With BIOPHYTIS company. C Bezier, O Biondi, F Charbonnier (INVENTORS)- pending international extension.
2) Patent FR3093640-2021 : « Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de maladies neuromusculaires ». 2021, with BIOPHYTIS company. C Bezier (INVENTOR), O Biondi, F Charbonnier (ICONTRIBUTORS)- pending international extension.
3) Patent n° 0758-IDF39-EP “A SERS-based method for diagnosing joint disease, European patent” 2019. C Ngueyen, F Rannou ; F Etienne. |
Documents non publiés |
Pré-publication, document de travail (ex BioXRiv) · Pubmed format (Titre, Auteur.rice.s, Journal, Date, numéro) ColQ binds to LRP4 and regulates MuSK/LRP4 activation by agrin at the neuromuscular junction Dobbertin A, Uyen Dao TM, Barbeau S, Messéant J, Della Gaspera B, Semprez F, Legay C. In positive revision in Journal of Biological Chemistry. NADPH Oxidase 4 inhibition is a complementary therapeutic strategy for Spinal muscular atrophy. M. El Khoury, L. Weill, O. Biondi1, D. Sapaly, S. Bendris, C. Bezier, Z. Clerc1, E. Abi Akar, F. Cheguillaume, G. Bruneteau, AA. Eid, F. Charbonnier. Submitted for publication. Drug candidate BIO101 for spinal muscular atrophy as monotherapy or combined with the antisens oligonucleotide AS0-10-27. C. Bézier, P. Nazari Hashemi, S. Cottin, M. El Khoury, Z. Clerc, C. Balducci, D. Sapaly, L. Weill, R. Lafont, S. Veillet, P. J. Dilda, F. Charbonnier, M. Latil, O. Biondi. Submitted for publication.
|
Rapport (expertises,…) – pour le nombre de jurys de thèse ou d’HDR (indiquer le nombre en tant que rapporteur ou examinateur sur la période par équipe) F Charbonnier (6 Thèses- Rapporteur) ; F Rannou (3 thèses et 2 HDR – Rapporteur) S Lefebvre (5 thèses dont 3 en tant que rapporteur) |
Travaux universitaires |
Thèse Houdebine Léo, « Étude de l’implication du métabolisme du cholestérol dans la pathogénèse des amyotrophies spinales infantiles », 2017, F Charbonnier D’amico Domenico, « Study of the involvement of the IRE1α-XBP1 branch of unfolded urotein response in spinal muscular atrophy », 2020, F Charbonnier El Khoury Mirella, « Etude du rôle des NADPH oxydases dans un modèle murin d’amyotrophie spinale », 2021, F Charbonnier Bézier Cynthia, « Etude des effets de BIO101 seul ou en combinaison avec des oligonucléotides antisens dans un modèle murin sévère d’amyotrophie spinale infantile », 2022, F Charbonnier & O Biondi Abi Akar Elias, « New exercise protocole approach for t2dm patients “Case study on aquatic for T2DM patients under a low calorie diet », 2022, F Charbonnier |
HDR Lefebvre Suzie, « Régulation du Métabolisme de l’ARN: du Noyau au Système Neuromusculaire dans l’Amyotrophie spinale », 2019. |